|
2024
|
Invention
|
Trans-cyclooctene with improved t-linker. transin vitroin vivoin vivoin vitrotranstrans-cycloocte... |
|
|
Invention
|
Tetrazines with improved properties. in vitroin vivoin vivo. |
|
2023
|
Invention
|
Bio-orthogonal drug activation.
The invention relates to a Prodrug activation method, for therap... |
|
|
Invention
|
Strained bicyclononenes. Disclosed herein are dienophiles, in particular strained bicyclononenes,... |
|
|
Invention
|
Masked il12 protein. in vitroin vivoin vivo. Surprisingly, a small, bioorthogonal group is suffic... |
|
2022
|
Invention
|
Cleavable tetrazine used in bio-orthogonal drug activation. A bound thereto and a dienophile, as ... |
|
|
Invention
|
Methods for preparing cyclooctenes andconjugates thereof.
The present invention pertains to impr... |
|
|
Invention
|
Methods for preparing cyclooctenes and conjugates thereof. The present invention pertains to impr... |
|
2021
|
P/S
|
chemical preparations for use in industry and science; chemical preparations and kits comprised o... |
|
|
Invention
|
Bio-orthogonal drug activation. The invention relates to a Prodrug activation method, for therape... |
|
2020
|
Invention
|
Chemically cleavable group.
Disclosed is the use of the reactive components of the inverse elect... |
|
|
Invention
|
Compounds for fast and efficient click release.
The invention disclosed herein relates to compou... |
|
|
Invention
|
Tetrazines for high click release speed and yield.
Disclosed herein are tetrazines substituted w... |
|
|
Invention
|
Agents for cleaving labels from biomolecules in vivo.
Disclosed herein are compounds, combinatio... |
|
|
Invention
|
Tetrazines for high click release speed and yield. Disclosed herein are tetrazines substituted wi... |
|
|
Invention
|
Agents for cleaving labels from biomolecules in vivo. Disclosed herein are compounds comprising t... |
|
|
Invention
|
Compounds for fast and efficient click release. The invention disclosed herein relates to compoun... |
|
2019
|
Invention
|
Compounds comprising a linker for increasing transcyclooctene stability.
Disclosed are compounds... |
|
|
Invention
|
Tetrazines for high click conjugation yield in vivo and high click release yield.
Disclosed here... |
|
|
Invention
|
Compounds comprising a linker for increasing transcyclooctene stability. Disclosed are compounds ... |
|
|
Invention
|
Tetrazines for high click conjugation yield in vivo and high click release yield. Disclosed herei... |
|
2017
|
Invention
|
Cleavable tetrazine used in bio-orthogonal drug activation. Disclosed is an advancement in provok... |
|
2013
|
Invention
|
Chemically cleavable group. Disclosed is the use of the reactive components of the inverse electr... |
|
|
Invention
|
Bio-orthogonal drug activation.
Disclosed is a kit for the administration and activation of a Pr... |
|
|
Invention
|
Channel protein activatable liposomes. Disclosed is a liposome, comprising a lipid bilayer enclos... |
|
|
Invention
|
Activatable liposomes. Disclosed are reactive liposome, comprising a lipid bilayer enclosing a ca... |
|
|
Invention
|
Bio-orthogonal drug activation. Disclosed is a kit for the administration and activation of a Pro... |
|
|
P/S
|
Chemical products for use in industry and science; chemical products or kits of chemical products... |
|
2012
|
Invention
|
Tetrazine derivatives used in bio-orthogonal drug activation. The invention relates to a Prodrug ... |
|
|
Invention
|
Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene. De... |
|
|
Invention
|
Pretargeting kit for imaging or therapy comprising a trans - cyclooctene dienophile and a diene. ... |
|
2011
|
Invention
|
Agents for clearing biomolecules from circulation. Described is a method, and a combination of ag... |
|
|
Invention
|
Pretargeting kit, method and agents used therein. Described is a pretargeting method, and related... |
|
2010
|
Invention
|
Pretargeting kit, method and agents used therein.
Described is a pretargeting method, and relate... |
